|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 31/00 | |
| A61P 31/06 | |||
| A61P 31/14 | |||
| A61P 33/02 | |||
| A61P 33/06 | |||
| A61P 35/00 | |||
| A61P 43/00 | |||
| A61K 39/00 | |||
| A61P 31/20 | |||
| C07K 16/28 |
| (11) | Number of the document | 3153526 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16198909.0 |
| Date of filing the European patent application | 2009-01-30 | |
| (97) | Date of publication of the European application | 2017-04-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 08300061 | 2008-01-31 | EP | |
| 08162683 | 2008-08-20 | EP |
| (72) |
LEVY, Yves, FR
ELIAOU, Jean-Franēois, FR
BENSUSSAN, Armand, FR
BONNEFOY-BERARD, Nathalie, FR
|
| (73) |
INSERM - Institut National de la Santé et de la Recherche Médicale,
101, rue de Tolbiac, 75013 Paris,
FR
|
| (54) | ANTIBODIES AGAINST HUMAN CD39 AND USE THEREOF FOR INHIBITING T REGULATORY CELLS ACTIVITY |
| ANTIBODIES AGAINST HUMAN CD39 AND USE THEREOF FOR INHIBITING T REGULATORY CELLS ACTIVITY |